Skip to content
2000
Volume 25, Issue 6
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background: Long-term immunosuppressive therapy, as provided to solid organ transplant recipients, inevitably results in a significant inhibition of immune defenses; this leads to frequent skin infections and malignancies, which represent an important cause of morbidity and mortality for transplanted patients. The incidence and risk of skin carcinomas are elevated in solid organ transplant recipients in comparison with the general population, with a 10-fold increased risk for basal cell carcinoma and a 50-100-fold for squamous cell carcinoma. The schedule of immunosuppressive drugs influences the type and timing of skin malignancies, but a crucial role is also played by endogenous and exogenous risk factors. Methods & Results: Here, we will review the state-of-the-art in chemoprevention of epidermal carcinomas in order to provide useful information for clinicians involved in the management of transplant recipients. One-hundred and forteen paper, published on peerreviewed journals, has been included. Conclusion: Chemoprevention would be key in controlling skin carcinogenesis in high-risk patients.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867324666171003123056
2018-02-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867324666171003123056
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test